Biomarkers for Use in Monitoring Responses of Nasopharyngeal Carcinoma Cells to Ionizing Radiation
Nasopharyngeal carcinoma (NPC) is a common head and neck cancer. The incidence rate is higher in southern China and Southeast Asia in comparison with the Western countries. Radiotherapy is the standard treatment of NPC as the cancer cells are sensitive to ionizing radiation. Radiation treatment has...
Main Authors: | Wei Gao, John Zenghong Li, Wai Kuen Ho, Jimmy Yuwai Chan, Thian Sze Wong |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2012-06-01
|
Series: | Sensors |
Subjects: | |
Online Access: | http://www.mdpi.com/1424-8220/12/7/8832 |
Similar Items
-
Biomarkers for enhancing the radiosensitivity of nasopharyngeal carcinoma
by: Wei Chen, et al.
Published: (2015-03-01) -
Hearing Loss in Patients with Nasopharyngeal Carcinoma after Chemotherapy and Radiation
by: Ling-Feng Wang, et al.
Published: (2003-04-01) -
Serum levels of α2 ⁃ macroglobulin in patients with nasopharyngeal carcinoma radiotherapy and its clinical significance
by: GE Yaping, et al.
Published: (2017-06-01) -
Ionizing Radiation Protein Biomarkers in Normal Tissue and Their Correlation to Radiosensitivity: A Systematic Review
by: Prabal Subedi, et al.
Published: (2021-02-01) -
Ionizing Radiation Protein Biomarkers in Normal Tissue and Their Correlation to Radiosensitivity: Protocol for a Systematic Review
by: Anne Dietz, et al.
Published: (2021-12-01)